Home Newsfeeds Wolfe Research Downgrades Southern Copper to Underperform

Wolfe Research Downgrades Southern Copper to Underperform

Wolfe Research analyst Timna Tanners downgrades Southern Copper (NYSE:SCCO) from Peer Perform to Underperform.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Wolfe Research analyst Timna Tanners downgrades Southern Copper (NYSE:SCCO) from Peer Perform to Underperform.

Medtronic, Merck, Williams Companies And More: CNBC’s ‘Final Trades’

By Priya Nigam

June 1, 8:21 AM

On CNBC’s "Halftime Report Final Trades," Anastasia Amoroso of JPMorgan Private Bank named iShares 7-10 Year Treasury Bond ETF (NASDAQ: IEF)

ESALY

First Bitcoin ETPs Begin Trading On London Stock Exchange

By Benzinga Neuro

May 28, 8:51 AM

Bitcoin (CRYPTO: BTC) exchange-traded products (ETPs) have commenced trading on the London Stock Exchange, marking a significant milestone for cryptocurrency adoption in the U.K.

BTC

Semtech Appoints Mark Lin As Executive Vice President And Chief Financial Officer

By Happy Mohamed

September 8, 4:16 PM

Semtech Corporation (NASDAQ:SMTC), a high-performance semiconductor, IoT systems, and cloud connectivity service provider, announced today that its board of directors has appointed Mark Lin as Semtech's new

SMTC

Amneal Pharmaceuticals Has Been Granted A CMS Permanent Product-Specific Reimbursement Q-code (Q5130) For Fylnetra Effective April 1, 2023

By Happy Mohamed

February 13, 3:24 PM

https://www.cms.gov/files/document/2022-hcpcs-application-summary-quarter-4-2022-drugs-and-biologicals-updated-02/01/2023.pdf

AMRX

Wolfe Research Downgrades Southern Copper to Underperform

Related Posts

Medtronic, Merck, Williams Companies And More: CNBC’s ‘Final Trades’

First Bitcoin ETPs Begin Trading On London Stock Exchange

Semtech Appoints Mark Lin As Executive Vice President And Chief Financial Officer

Amneal Pharmaceuticals Has Been Granted A CMS Permanent Product-Specific Reimbursement Q-code (Q5130) For Fylnetra Effective April 1, 2023